BMI-Based Eligibility BMI 30: You may meet general BMI-based criteria, but final eligibility requires provider review
This approach works best for people whose genetic profile shows strong sensitivity to GLP-1 signaling and those who struggled with appetite control before treatment
PKM2, M2 isoform of pyruvate kinase
Peptide therapy uses short chains of amino acids natural signaling molecules your body already produces in physician-prescribed doses to support specific goals like muscle recovery, metabolism, sleep quality, skin health, cognitive focus, and healthy aging
It supports healing from ulcers, leaky gut syndrome, IBS, and other inflammatory bowel issues